Sanofi-Aventis Groupe

Industry / private company

Location: Paris, France (FR) FR



Show on Map:


Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year




Laboratory and free-living gait performance in adults with COPD and healthy controls (2023) Buekers J, Megaritis D, Koch S, Alcock L, Ammour N, Becker C, Bertuletti S, et al. Journal article Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement–the Mobilise-D study protocol (2022) Mikolaizak AS, Rochester L, Maetzler W, Sharrack B, Demeyer H, Mazzà C, Caulfield B, et al. Journal article Elucidation of the Application of Blood Test Biomarkers to Predict Immune-Related Adverse Events in Atezolizumab-Treated NSCLC Patients Using Machine Learning Methods (2022) Zhou JG, Wong AHH, Wang H, Tan F, Chen X, Jin SH, He SS, et al. Journal article Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project) (2022) Bernabei R, Landi F, Calvani R, Cesari M, Del Signore S, Anker SD, Bejuit R, et al. Journal article Machine learning based on blood biomarkers predicts fast progression in advanced NSCLC patients treated with immunotherapy (2022) Zhou JG, Yang J, Wang H, Wong AHH, Tan F, Chen X, He S, et al. Conference contribution Diffusivity mapping of the ovaries: Variability of apparent diffusion and kurtosis variables over the menstrual cycle and influence of oral contraceptives (2021) Mokry T, Pantke J, Mlynarska-Bujny A, Hasse FC, Kuder TA, Schlemmer HP, Kauczor HU, et al. Journal article Treatment preferences for preventive interventions for rheumatoid arthritis: Protocol of a mixed methods case study for the Innovative Medicines Initiative PREFER project (2021) Falahee M, Simons G, Disantostefano RL, Valor Méndez L, Radawski C, Englbrecht M, Schölin Bywall K, et al. Journal article, Original article A cell-based drug delivery platform for treating central nervous system inflammation. (2021) Levy O, Rothhammer V, Mascanfroni I, Tong Z, Kuai R, De Biasio M, Wang Q, et al. Journal article Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database. (2020) Allanore Y, Bozzi S, Terlinden A, Huscher D, Amand C, Soubrane C, Siegert E, et al. Journal article Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblasts of patients with scleroderma to tight skin 1 mouse (2020) Ledein L, Léger B, Dees C, Beyer C, Distler A, Vettori S, Boukaiba R, et al. Journal article